Choose Rich Live
Tech

AstraZeneca partners with insitro in AI drug discovery deal for heart and liver diseases

AstraZeneca has formed a drug discovery partnership with machine learning startup insitro to target heart and liver diseases, paying $40 million upfront in a deal that could include up to $1.5 billion in milestones.

AstraZeneca logo on an exterior office building wall behind green leaves.
Image: @analyticsinme

AstraZeneca has partnered with artificial intelligence drug discovery startup insitro to search for new treatments for serious heart and liver diseases. According to Quartz, AstraZeneca is paying $40 million upfront, with insitro eligible for up to roughly $1.46 billion to $1.5 billion in milestone payments, alongside single-digit royalties on global sales of resulting products.[1][2][5][6][7]

Bloomberg reported that the collaboration with the machine learning biotech is valued at as much as $1.86 billion.[3][4]

The collaboration follows research setbacks for AstraZeneca in both heart and liver diseases, areas Quartz reported the drugmaker has struggled to solve on its own. AstraZeneca is turning to insitro's "Virtual Human AI" platform to identify potential disease targets that might otherwise be missed.[5][7][8]

Key facts

  • AstraZeneca formed an AI drug discovery partnership with insitro to discover targets for liver and heart diseases.
  • AstraZeneca agreed to pay insitro $40 million upfront under the agreement.
  • Insitro is eligible for milestone payments reaching up to $1.46 billion to $1.5 billion.
  • The agreement includes single-digit royalties on global product sales for insitro.
  • Bloomberg reported the collaboration is worth as much as $1.86 billion.
  • AstraZeneca turned to insitro's 'Virtual Human AI' platform following research setbacks in heart and liver disease.

Sources ยท 5 sources

  1. AI

    Analytics Insight@analyticsinmePost on X ยท

    ๐€๐ฌ๐ญ๐ซ๐š๐™๐ž๐ง๐ž๐œ๐š ๐š๐ง๐ ๐ข๐ง๐ฌ๐ข๐ญ๐ซ๐จ ๐’๐ข๐ ๐ง ๐”๐’๐ƒ ๐Ÿ.๐Ÿ“ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐€๐ˆ ๐ƒ๐ซ๐ฎ๐  ๐ƒ๐ข๐ฌ๐œ๐จ๐ฏ๐ž๐ซ๐ฒ ๐๐š๐ซ๐ญ๐ง๐ž๐ซ๐ฌ๐ก๐ข๐ฉ AstraZeneca is turning to AI to explore new treatments for serious liver and heart diseases. Its partnership with insitro includes USD 40 million upfront and up to USD 1.46 billion in potential milestone payments. Can AI help researchers find new drug targets faster? #AstraZeneca #Insitro #ArtificialIntelligence #DrugDiscovery #HealthTech #Biotechnology #AI #AINews #AnalyticsInsight #AnalyticsInsightMagazine ย  Read More ๐Ÿ‘‡ https://t.co/zs1enMKrWX

    Open source
  2. QU

    Quartz@qzPost on X ยท

    AstraZeneca is paying insitro $40 million upfront to find liver and heart drug targets: Insitro is eligible for up to about $1.โ€‹46 billion in milestone payments, plus single-digit royalties on global sales dlvr.โ€‹it/TVwdgf https://t.co/84ZEeHNIhE

    Open source
  3. CB

    Crypto BriefingArticle ยท

    AstraZeneca signs AI drug discovery deal with insitro worth up to $1.86 billion This collaboration highlights the growing reliance on AI in pharma, potentially accelerating drug discovery and reshaping industry dynamics. The post AstraZeneca signs AI drug discovery deal with insitro worth up to $1.86 billion appeared first on Crypto Briefing .

    Open source
  4. BL

    Bloomberg@businessPost on X ยท

    AstraZeneca is collaborating with machine learning biotech Insitro. in a deal worth as much as $1.86 billion https://t.co/U0jHBxj7Eq

    Open source
  5. QU

    Quartz@qzPost on X ยท

    AstraZeneca bets $40M on AI to crack liver and heart diseases it's struggled to crack alone AstraZeneca is partnering with AI startup insitro โ€” handing over $40 million upfront and up to $1.5 billion in milestones โ€” to hunt for drug target #AstraZeneca #insitro #AIDrugDiscovery https://t.co/CoAhlTs0VP

    Open source
  6. ET

    Economic Times@EconomicTimesPost on X ยท

    AstraZeneca strikes $40 million AI drug discovery deal with insitro https://t.co/Q7FRjsyJFC

    Open source
  7. QU

    Quartz@qzPost on X ยท

    AstraZeneca bets $40M on AI to crack liver and heart diseases it's struggled to crack alone: AstraZeneca is partnering with AI startup insitro โ€” handing over $40 million upfront and up to $1.โ€‹5 billion in milestones โ€” to hunt for drug targets inโ€ฆ dlvr.โ€‹it/TVwbT9 #AstraZeneca #AI https://t.co/IcgdzgoATj

    Open source
  8. QU

    Quartz@qzPost on X ยท

    AstraZeneca bets $1.5B on AI to crack diseases it couldn't solve alone After setbacks in both heart and liver disease research, AstraZeneca is turning to Insitro's 'Virtual Human AI' platform to find drug targets it might otherwise miss en #AstraZeneca #Insitro #AIDrugDiscovery https://t.co/iN1TvDW1ii

    Open source